Key points are not available for this paper at this time.
Regarding the reduction of graphene oxide (GO), which is usually carried out by conventional methods, which brings with it technical problems and socio-environmental concerns related to the use of hazardous chemical compounds, such as hydrazine and sodium borohydride, to avoid these risks, in this work, a new and safer approach is reported for the preparation of RGO based on naringenin, a natural flavonoid found in citrus residues, being used as a green reducing agent. Morphological analysis via SEM revealed a veil-like structure with fewer wrinkles and agglomerates in RGO/naringenin samples. XRD analysis showed the disappearance of the GO peak at 10° and the emergence of a broad shoulder around 26°, indicating partial restoration of graphitic domains. FTIR spectra indicated a significant decrease in O–H and C=O bands, consistent with removal of oxygen-containing groups. Raman analysis demonstrated a reduction in structural defects, with the ID/IG ratio decreasing from 1.03 (GO) to 0.93 (RGO/naringenin). TGA results showed improved thermal stability, with an increase in residual mass from 26.6% (pure RGO) to 34.1% (RGO/naringenin). DSC analysis corroborated these findings by displaying milder exothermic events. These results confirm the efficacy of naringenin as a sustainable and efficient reducing agent for RGO production.
Júnior et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: